Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Leuprolide Acetate

Leuprolide Acetate ▴ Leuprolide acetate (leuprorelin) is a luteinizing hormone-releasing hormone agonist used in the palliative treatment of advanced prostate cancer. A new, non-biodegradable, subcutaneous implant, containing 72mg leuprolide acetate (equivalent to 65mg leuprolide free base), uses osmotic pressure to deliver leuprolide at a constant rate over 1 year. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Loading next page...
 
/lp/springer-journals/leuprolide-acetate-Hef1WAb0wh

References (45)

Publisher
Springer Journals
Copyright
Copyright © 2003 by Adis International Limited
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200302010-00004
Publisher site
See Article on Publisher Site

Abstract

▴ Leuprolide acetate (leuprorelin) is a luteinizing hormone-releasing hormone agonist used in the palliative treatment of advanced prostate cancer. A new, non-biodegradable, subcutaneous implant, containing 72mg leuprolide acetate (equivalent to 65mg leuprolide free base), uses osmotic pressure to deliver leuprolide at a constant rate over 1 year.

Journal

American Journal of CancerSpringer Journals

Published: Aug 10, 2012

There are no references for this article.